Skip to main content

Market Overview

Mid-Afternoon Market Update: Loxo Oncology Surges After Positive Results From Larotrectinib Trial; Microbot Medical Shares Plunge


Toward the end of trading Monday, the Dow traded down 0.03 percent to 21,200.33 while the NASDAQ slipped 0.07 percent to 6,301.27. The S&P also fell, dropping 0.04 percent to 2,438.03.

Leading and Lagging Sectors

Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), SM Energy Co (NYSE: SM), and Ecopetrol SA (ADR) (NYSE: EC).

In trading on Monday, utilities shares fell 0.48 percent. Meanwhile, top losers in the sector included Genie Energy Ltd (NYSE: GNE), down 3 percent, and Southwest Gas Holdings Inc (NASDAQ: SWX), down 2.5 percent.

Top Headline

Herbalife Ltd. (NYSE: HLF) cut its sales forecast for the current quarter.

Herbalife expects Q2 revenue to decline by 6 percent to 2 percent, versus earlier forecast of 0.5 percent to 4.5 percent decline. It projects adjusted earnings of $0.95 to $1.15 per share, up from previous forecast of $0.88 to $1.08 per share.

Equities Trading UP

Forestar Group Inc. (NYSE: FOR) shares shot up 13 percent to $16.00 after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.

Shares of Loxo Oncology Inc (NASDAQ: LOXO) got a boost, shooting up 46 percent to $71.54 following the announcement of a 76 percent-confirmed objective response rate for the trial of Larotrectinib for the treatment for multiple forms of cancer. Citigroup upgraded Loxo Oncology from Neutral to Buy.

Dynavax Technologies Corporation (NASDAQ: DVAX) shares were also up, gaining 17 percent to $6.88 after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.

Equities Trading DOWN

Microbot Medical Inc (NASDAQ: MBOT) shares dropped 34 percent to $2.50. Microbot Medical reported a $10 million registered direct offering

Shares of NewLink Genetics Corp (NASDAQ: NLNK) were down 12 percent to $11.13 after the company reported that indoximod + PROVENGE resulted in statistically significant improvement in rPFS for patients with mCRPC in Phase 2 trial.

Herbalife Ltd. (NYSE: HLF) was down, falling around 8 percent to $67.98 after the company cut its sales forecast for the current quarter.


In commodity news, oil traded down 0.65 percent to $47.35 while gold traded up 0.09 percent to $1,281.40.

Silver traded up 0.14 percent Monday to $17.55, while copper fell 0.49 percent to $2.562.


European shares closed lower today. The eurozone’s STOXX 600 fell 0.13 percent, the Spanish Ibex Index fell 0.19 percent, while Italy’s FTSE MIB Index fell 0.99 percent. Meanwhile the French CAC 40 declined 0.66 percent while U.K. shares fell 0.29 percent.


U.S. nonfarm productivity was unchanged for the first quarter, versus economists’ expectations for a 0.20 percent decline. Unit labor costs rose 2.20 percent for the quarter, versus estimates for a 2.50 percent growth.

US Services PMI declined to 53.60 in May, versus a prior reading of 54.00. Economists expected a reading of 54.10.

U.S. factory orders declined 0.2 percent for April, versus economists’ expectations for a 0.20 percent drop.

The ISM non-manufacturing index slipped to 56.90 for May, versus previous reading of 57.50. Economists were expecting a reading of 57.00.

The Conference Board Employment Trends Index rose to 133.70 in May, versus a prior revised reading of 132.77.


Related Articles (DVAX + DHI)

View Comments and Join the Discussion!

Posted-In: Earnings M&A News Guidance Eurozone Commodities Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at